Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for organ protection in elderly patients undergoing one-lung ventilation during esophageal cancer surgery
ChiCTR-IPR-17013956Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in Perioperative organ injury (POI) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Neuron-specific enolase, S100 beta protein and 3 more. Started Feb 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Perioperative organ injury (POI)
Beyond the preview
Go deeper on ChiCTR-IPR-17013956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013956.